Recent Updates in treatment of Urticaria

Speciality: Dermatology

Description:

A warm welcome to all the medical professionals in this interesting session on Recent Updates in treatment of Urticaria
Recent advancements in the treatment of urticaria, particularly chronic spontaneous urticaria (CSU), have brought new hope for patients struggling with this condition. Traditionally managed with antihistamines, treatment approaches are evolving with the introduction of biologics like omalizumab, an anti-IgE monoclonal antibody. Omalizumab has shown significant efficacy in reducing hives and itchiness in patients who do not respond adequately to high doses of antihistamines, offering a targeted and effective alternative.
In addition to biologics, there is growing interest in the role of other immunomodulatory therapies in managing urticaria. Research into medications such as cyclosporine, which suppresses the immune system, has shown promise for patients with severe, refractory cases. These therapies provide additional options for individuals who have exhausted standard treatments, highlighting the importance of personalized medicine in addressing the diverse needs of urticaria patients.
Therefore, get an overall knowledge of recent updates in treatment of urticaria
 

See More Webinars @ Hidoc Webinars